Mark A Lemmon, PhD, FRSAlfred Gilman Professor and Chair of Pharmacology; Co-director, Cancer Biology InstituteResearch InterestsMAP Kinase Signaling SystemHydrogen Deuterium Exchange-Mass SpectrometryErbB ReceptorsCrystallographyAdenocarcinomaCell MembraneBiochemistryProtein Kinase InhibitorsProtein Structure, TertiarySignal TransductionSingle Molecule ImagingProtein-Tyrosine KinasesReceptor AggregationView Full Profile